Celltrion USA launches ZYMFENTRA for ulcerative colitis and Crohn’s disease

In a significant advancement for patients with digestive disorders, Celltrion USA has announced the availability of ZYMFENTRA (infliximab-dyyb), marking it as the first and only ... Read More